Swati Sharma, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

Navigating Psychedelics Q&A: Essential Skills for Psychedelic Practitioners

Psychedelic Education: Insights, Advice, and Where to Start

Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to...

Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science

Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch

Self Awareness and Inner Work: Essential Skills for Psychedelic-Informed Practitioners

Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy...

The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence

Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes...

1...222324...217 Page 23 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin